Sign in

CIK 0001084267

  • Non-accelerated filer
  • Smaller reporting company

Mobiquity Technologies, Inc.

Sign in to watch
Tickers
MOBQ MOBQW
Exchange
OTC
Industry
Services-Advertising
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
113427886
Phone
+1 516-256-7766
Business address
35 TORRINGTON LANE, SHOREHAM, NY, 11786
Former names
ACE MARKETING & PROMOTIONS INC

Securities

  • MOBQ Common stock OTC
  • MOBQW Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-12-31 Salkind Gene Director Grant or award · Common Stock Options +250,000 761,544
2025-09-15 Salkind Gene Director Grant or award +25,000 $1.00 $25K 8,668,695
2025-09-15 Salkind Gene Director Grant or award · Convertible notes +100,000 511,544
2024-12-30 Salkind Gene Director Option exercise +420,000 $0.50 $210K 8,643,695
2024-12-30 Salkind Gene Director Option exercise · Convertible notes −210,000 411,544
2024-10-08 Salkind Gene Director Grant or award · Common Stock Options +250,000 831,544
2024-08-06 Salkind Gene Director Conversion +7,675,160 $0.20 $1.5M 8,223,695
2024-08-06 Salkind Gene Director Conversion · Series H Preferred Stock −751,973 581,544
2024-08-06 Salkind Gene Director Conversion +7,675,160 $0.20 $1.5M 8,223,695
2024-08-06 Salkind Gene Director Conversion · Series H Preferred Stock −751,973 616,201
2024-07-25 Salkind Gene Director Grant or award · Convertible Promissory Notes +50,000 8,135,931
2024-06-27 Salkind Gene Director Grant or award · Convertible Promissory Notes +160,000 8,035,931
2023-12-19 Salkind Gene Director Grant or award · Common stock options +100,000 7,715,931
2023-12-15 Salkind Gene Director Grant or award · Preferred Stock Series G −300,789 3,103,990
2023-12-15 Salkind Gene Director Returned to the company · Preferred Stock Series H +751,973 7,615,931
2023-11-07 Salkind Gene Director Exercise or conversion · Common Stock −0 96,100
2023-11-07 Salkind Gene Director Grant or award · Preferred Stock +300,789 3,103,990
2023-10-06 Salkind Gene Director Grant or award +150,000 $0.65 $98K 448,535
2023-10-06 Salkind Gene Director Grant or award · Common Stock +0 524,671
2023-10-06 Salkind Gene Director Grant or award +150,000 $0.65 $98K 448,535

Page 1 of 3 · 54 trades